Franz Skincare

Franz Skincare is a groundbreaking skincare company that is revolutionizing the industry with its patented technology. Their microcurrent face masks are designed to penetrate the skin six times deeper than traditional topical masks, offering a unique approach to skincare. The company's success can be attributed to a multidisciplinary collaboration with scientists at Seoul National University and The Samsung Hospital, resulting in the development of the innovative TDDS trademarked as Tissue X Technology. With an initial investment of $10 million in R&D, Franz Skincare has achieved remarkable results, enabling active ingredients to penetrate deeply without the need for additional tools or devices. These exceptional clinical results surpass most conventional procedures performed by physicians or practitioners.

Founded in 2013, Franz Skincare operates within the E-Commerce, Health Care, Retail, and Wellness Beauty industries. While details regarding their headquarters, last investment, and investors are currently unavailable, the company's commitment to innovation and scientific collaboration positions them as an intriguing prospect for potential investors in the skincare and beauty sector. Their focus on cutting-edge technology and clinically-proven results demonstrates the potential for significant growth and market impact.